title: [Breast cancer and the hand-foot syndrome].
abstract: Regarding patients being treated for breast cancer and on oral capecitabine, the main side effect is the hand-foot syndrome (HFS), or Palmar-Plantar Erythrodysesthesia (PPE).). This could be inconvenient or even debilitating depending on the grade. The Day Care Centre at the Institut Curie in Paris (75) conducted a prospective study on patients treated with oral capecitabine for advanced breast cancer, to assess the rate of appearance of the hand-foot syndrome and the impact of paramedical follow-up on the occurrence of this side effect.
authors.affiliation: Hôpital de jour, département d'oncologie médicale, Institut Curie, Paris. claire.llambrichmolines@curie.net
authors.forename: Claire
authors.initials: C
authors.lastname: Llambrich
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Falcou
authors.forename: Yann
authors.initials: Y
authors.lastname: De Rycke
authors.forename: Paul
authors.initials: P
authors.lastname: Cottu
authors.forename: Sylvie
authors.initials: S
authors.lastname: Carrié
authors.forename: Malika
authors.initials: M
authors.lastname: Medjbari
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D060831:Hand-Foot Syndrome / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D010297:Paris; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil